|
1
|
Maher ER, Iselius L, Yates JR, Littler M,
Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA and
Morton N: Von Hippel-Lindau disease: A genetic study. J Med Genet.
28:443–447. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neumann HP and Wiestler OD: Clustering of
features of von Hippel-Lindau syndrome: Evidence for a complex
genetic locus. Lancet. 337:1052–1054. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maher ER, Yates JR, Harries R, Benjamin C,
Harris R, Moore AT and Ferguson-Smith MA: Clinical features and
natural history of von Hippel-Lindau disease. Q J Med.
77:1151–1163. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maher ER and Kaelin WG Jr: von
Hippel-Lindau disease. Medicine (Baltimore). 76:381–391. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clifford SC and Maher ER: Von
Hippel-Lindau disease: Clinical and molecular perspectives. Adv
Cancer Res. 82:85–105. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hwang JJ, Uchio EM, Pavlovich CP, Pautler
SE, Libutti SK, Linehan WM and Walther MM: Surgical management of
multi-organ visceral tumors in patients with von Hippel-Lindau
disease: A single stage approach. J Urol. 169:895–898. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson LD: Pheochromocytoma of the
Adrenal gland Scaled Score (PASS) to separate benign from malignant
neoplasms: A clinicopathologic and immunophenotypic study of 100
cases. Am J Surg Pathol. 26:551–566. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kutikov A, Crispen PL and Uzzo RG:
Pathophysiology, evaluation, and medical management of adrenal
disordersCampbell's Urology. Wein AJ A.J..Kavoussi LR L.R..Novick
AC A.C..Partin AW A.W..Peters CA C.A.: Elsevier Saunders; pp.
1685–1736. 2012, View Article : Google Scholar
|
|
9
|
Esen T, Acar O, Tefekli A, Musaoğlu A,
Rozanes I and Emre A: Adrenal cortex-sparing surgery for bilateral
multiple pheochromocytomas in a patient with von hippel-lindau
disease. Case Rep Med. 2012:6591042012.PubMed/NCBI
|
|
10
|
Crippa S, Partelli S, Zamboni G, Scarpa A,
Tamburrino D, Bassi C, Pederzoli P and Falconi M: Incidental
diagnosis as prognostic factor in different tumor stages of
nonfunctioning pancreatic endocrine tumors. Surgery. 155:145–153.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheema A, Weber J and Strosberg JR:
Incidental detection of pancreatic neuroendocrine tumors: An
analysis of incidence and outcomes. Ann Surg Oncol. 19:2932–2936.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mukhopadhyay D, Knebelmann B, Cohen HT,
Ananth S and Sukhatme VP: The von Hippel-Lindau tumor suppressor
gene product interacts with Sp1 to repress vascular endothelial
growth factor promoter activity. Mol Cell Biol. 17:5629–5639. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cherif R, Gaujoux S, Couvelard A, Dokmak
S, Vuillerme MP, Ruszniewski P, Belghiti J and Sauvanet A:
Parenchyma-sparing resections for pancreatic neuroendocrine tumors.
J Gastrointest Surg. 16:2045–2055. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Libutti SK, Choyke PL, Bartlett DL, Vargas
H, Walther M, Lubensky I, Glenn G, Linehan WM and Alexander HR:
Pancreatic neuroendocrine tumors associated with von Hippel Lindau
disease: Diagnostic and management recommendations. Surgery.
124:1153–1159. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ,
Lee JW, Jun ES, Sin SH, Kim HE, Park KM, et al: Enucleation for
benign or low-grade malignant lesions of the pancreas:
Single-center experience with 65 consecutive patients. Surgery.
158:1203–1210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang RC, Zhou YC, Mou YP, Huang CJ, Jin
WW, Yan JF, Wang YX and Liao Y: Laparoscopic versus open
enucleation for pancreatic neoplasms: Clinical outcomes and
pancreatic function analysis. Surg Endosc. 30:2657–2665. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Mestier L, Gaujoux S, Cros J, Hentic O,
Vullierme MP, Couvelard A, Cadiot G, Sauvanet A, Ruszniewski P,
Richard S, et al: Long-term prognosis of resected pancreatic
neuroendocrine tumors in von Hippel-Lindau disease is favorable and
not influenced by small tumors left in place. Ann Surg.
262:384–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weisbrod AB, Kitano M, Thomas F, Williams
D, Gulati N, Gesuwan K, Liu Y, Venzon D, Turkbey I, Choyke P, et
al: Assessment of tumor growth in pancreatic neuroendocrine tumors
in von Hippel Lindau syndrome. J Am Coll Surg. 218:163–169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
